EX-23.1 4 tenx_ex231.htm CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, CHERRY BEKAERT LLP Blueprint
 
Exhibit 23.1
 
Consent of Independent Registered Public Accounting Firm
 
We consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated April 2, 2018, relating to the consolidated financial statements of Tenax Therapeutics, Inc. (the “Company”), appearing in the Annual Report on Form 10-K of the Company for the year ended December 31, 2017, and to the reference to our firm under the heading “Experts” in the prospectus.
 
 
/s/ CHERRY BEKAERT LLP
 
 
Raleigh, North Carolina
May 15, 2018